The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial

por Coyne, Daniel W
Publicado 2012

The future of intravenous iron in nephrology

por Coyne, Daniel W.
Publicado 2011

Iron Overload in Dialysis Patients: Rust or Bust?

por Coyne, Daniel W.
Publicado 2017

The Author Replies

por Coyne, Daniel W.
Publicado 2017

The Author Replies

por Coyne, Daniel W.
Publicado 2017

Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease

por Cheng, Steven, Coyne, Daniel
Publicado 2006

Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease

por Larson, Derek S., Coyne, Daniel W.
Publicado 2013

Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease

por Abbas, Fizza, Coyne, Daniel W.
Publicado 2019

Testing Vitamin D Analogues for Vascular Calcification in Patients With CKD

por Ramakrishnan, Madhuri, Coyne, Daniel W.
Publicado 2020

Changing the paradigms for the treatment of chronic kidney disease

por Coyne, Daniel W., Kovesdy, Csaba P.
Publicado 2017

New options for the anemia of chronic kidney disease

por Coyne, Daniel W., Goldsmith, David, Macdougall, Iain C.
Publicado 2017

Phosphate Balance and CKD–Mineral Bone Disease

por Sprague, Stuart M., Martin, Kevin J., Coyne, Daniel W.
Publicado 2021

Management of Post-transplant Hyperparathyroidism and Bone Disease

por Delos Santos, Rowena, Rossi, Ana, Coyne, Daniel, Maw, Thin Thin
Publicado 2019

Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence

por Coyne, Daniel W., Sprague, Stuart M., Vervloet, Marc, Ramos, Rosa, Kalantar-Zadeh, Kamyar
Publicado 2022

Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study

por Coyne, Daniel W., Andress, Dennis L., Amdahl, Michael J., Ritz, Eberhard, de Zeeuw, Dick
Publicado 2013

Serum Phosphorus and Pill Burden Among Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide: One-Year Follow-Up on a Contemporary Cohort

por Kendrick, Jessica B, Zhou, Meijiao, Ficociello, Linda H, Parameswaran, Vidhya, Mullon, Claudy, Anger, Michael S, Coyne, Daniel W
Publicado 2022

A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia

por Kalra, Philip A., Bhandari, Sunil, Saxena, Sanjiv, Agarwal, Dhananjai, Wirtz, Georg, Kletzmayr, Josef, Thomsen, Lars L., Coyne, Daniel W.
Publicado 2016

Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study

por Kalantar-Zadeh, Kamyar, Ficociello, Linda H., Parameswaran, Vidhya, Athienites, Nicolaos V., Mullon, Claudy, Kossmann, Robert J., Coyne, Daniel W.
Publicado 2019

Sucroferric Oxyhydroxide in Maintenance Hemodialysis: A Retrospective, Comparative Cohort Study

por Coyne, Daniel W., Ficociello, Linda H., Parameswaran, Vidhya, Rosen, Melissa M., Mullon, Claudy, Kossmann, Robert J., Sprague, Stuart M.
Publicado 2020

Molecular diversity of Scutellonema bradys populations from Benin, based on ITS1 rDNA and COI mtDNA

por Etchiha Afoha, Sètondji Alban Paterne, Affokpon, Antoine, Waeyenberge, Lieven, de Sutter, Nancy, Agbangla, Clément, Dansi, Alexandre, Coyne, Daniel L., Viaene, Nicole
Publicado 2018